Swords Laboratories, the Irish unit of pharmaceutical giant Bristol Myers Squibb, experienced a 42% decline in profits for the year 2023. This drop was attributed to a change in product mix, leading to a 10% decrease in revenue to $15.5 billion. The company is investing $400 million in a new biologics facility in Dublin, which will create 300 new jobs.
Profits slumped 42% at the main Irish unit of pharma giant Bristol Myers Squibb (BMS) as a decision to change the unit’s product mix saw revenues fall by 10 per cent to $15.5 billion (€15 billion). Swords Laboratories , based in north Dublin, manufactures biopharma and bulk active pharmaceutical ingredient product for businesses in the wider group. The $15.
5 billion sales figure in the accounts for 2023, filed in recent days, equate to about a third of BMS’s global revenues of $45 billion in that year. The directors said revenues fell by $917.52 million due to a change in product mix, pricing and volume, and the timing of the manufacture and distribution of new products. That was partly behind the 42 per cent slide in profits to €3.97 billion for the year. The company also booked $113.6 million in stock write-offs and suffered an adverse $60 million swing on foreign exchange. And it paid a dividend of $5.4 billion, up from $4.82 billion the previous year. The company subsequently paid dividends of $900 million after the year-end.Swords Labs, which has been operating here since November 1977, is investing $400 million in a new biologics sterile product facility at its Cruiserath campus in Mulhuddart — the company’s first such facility in Europe. That will add about 300 staff to the workforce which stood at 1,120 at the end of 2023, up 196 on the previous year. Staff costs increased from $141.6 million to $176.07 million which includes salaries and wages of $140.84 million and share-based compensation costs of $6.8 million and other employee costs of $3.2 million. At the end of December 2023, Swords Laboratories UC’s shareholder funds were $1.3 billion, including accumulated profits of $297.47 millio
Bristol Myers Squibb Swords Laboratories Irish Unit Profit Decline Product Mix Biologics Facility Investment Jobs
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pat Lam's Return to Irish Rugby Spotlight with Bristol BearsPat Lam, the former head coach of Connacht, now leads the Bristol Bears and finds himself back in the Irish rugby scene. Known for his offensive tactics, Lam discusses his rugby philosophy and reminisces on his past successes and relationships in an interview.
Read more »
Here's What Team STELLAR Is Loving This WeekSTELLAR Magazine, Irish Fashion, Irish Women's Magazine, Irish Beauty, shops in Ireland, celebrity news, glossy magazine, Fade Street, make-up tips, Irish style, Vip Magazine Group
Read more »
Why Can't Fashion Quit Smoking?STELLAR Magazine, Irish Fashion, Irish Women's Magazine, Irish Beauty, shops in Ireland, celebrity news, glossy magazine, Fade Street, make-up tips, Irish style, Vip Magazine Group
Read more »
How To Make The Most Of Your Christmas LeftoversSTELLAR Magazine, Irish Fashion, Irish Women's Magazine, Irish Beauty, shops in Ireland, celebrity news, glossy magazine, Fade Street, make-up tips, Irish style, Vip Magazine Group
Read more »
Here's What Team STELLAR Is Loving This WeekSTELLAR Magazine, Irish Fashion, Irish Women's Magazine, Irish Beauty, shops in Ireland, celebrity news, glossy magazine, Fade Street, make-up tips, Irish style, Vip Magazine Group
Read more »
Tonnes Of Leftover Christmas Chocolate? Here's What You Should Do With ItSTELLAR Magazine, Irish Fashion, Irish Women's Magazine, Irish Beauty, shops in Ireland, celebrity news, glossy magazine, Fade Street, make-up tips, Irish style, Vip Magazine Group
Read more »